智齒一定要拔嗎？可以一次拔兩顆嗎？｜證據鏈

智齒一定要拔嗎？可以一次拔兩顆嗎？｜證據鏈

F-Units（事實單元帳）

• F1｜本題選題依據＝14 診所站 GSC 全量對帳，本題屬生產佇列頁「三、診所補題」區（非主佇列 50 題），查詢「智齒一定要拔嗎」曝光 19,331，來源站單一｜來源 #18｜confidence=high｜basis=internal_dataset｜period=GSC 保留窗（2025-03-22 起）｜geo: TW｜caveat：曝光為屬性級數字、非去重流量；本欄為內部數據，非醫學宣稱，發布轉檔時整條剝除。
• F2［結構性整理］｜本卡的三層分流骨幹（立即就醫／盡快看診／可安排評估與追蹤）、「保留的已知風險 vs 拔除的已知風險」對照結構、每組數字的分母標註原則、「一次拔幾顆」改寫為「由誰評估、評估什麼」的處理方式，以及與 KM-DENTAL-01／04／40／21／05／33 的同族分工聲明，均為本站依 F3 至 F21 文獻整理的就醫溝通結構｜來源 #20｜confidence=n/a｜basis=editorial_framework｜period=2026-08-06｜geo: universal｜caveat：非診斷工具、非臨床分類，不得標為待驗；本欄不含任何療效或時程宣稱。
• F3｜Cochrane 系統性回顧（無症狀且無疾病之阻生智齒：手術拔除相對於保留）：結論為現有證據不足以判定應拔除或保留；保留可能與長期鄰近第二大臼齒牙周炎風險增加有關，惟該證據確定性為極低；鑑於現有證據不足，應考量病人價值觀並運用臨床專業以共同決策；若決定保留，建議以固定間隔進行臨床評估以預防不良結果｜來源 #1｜confidence=verified｜basis=peer_reviewed（PMID 32368796，Cochrane 系統性回顧 CD003879.pub5）｜period=2020（檢索至 2019-05-10）；版本鏈與撤回查核已做——2026-08-06 以 `CD003879` 檢索 PubMed 回傳 4 筆（15846686／22696337／27578151／32368796），本篇 pub5 為現行最新版；四筆 esummary pubtype 皆無 Retracted Publication／標題無 WITHDRAWN｜geo: universal｜span:「Insufficient evidence is available to determine whether asymptomatic disease-free impacted wisdom teeth should be removed or retained」「Although retention of asymptomatic disease-free impacted wisdom teeth may be associated with increased risk of periodontitis affecting adjacent second molars in the long term, the evidence is very low certainty」「Given the current lack of available evidence, patient values should be considered and clinical expertise used to guide shared decision-making with people who have asymptomatic disease-free impacted wisdom teeth」「If the decision is made to retain these teeth, clinical assessment at regular intervals to prevent undesirable outcomes is advisable」｜caveat：本回顧的範圍限於「無症狀且無疾病」的阻生智齒，不涵蓋已有症狀或已有病理變化者；「證據不足以判定」是對研究證據的評價，不等於兩種做法效果相同，亦不得被讀成鼓勵自行決定不就醫。
• F4｜同一回顧之背景敘述：阻生智齒可能與冠周炎、牙根吸收、牙齦與齒槽骨疾病（牙周炎）、蛀牙以及囊腫與腫瘤的發生等病理變化有關；當手術拔除在較年長者身上執行時，術後併發症、疼痛與不適的風險增加｜來源 #1｜confidence=verified｜basis=peer_reviewed（PMID 32368796）｜period=2020｜geo: universal｜span:「Impacted wisdom teeth may be associated with pathological changes, such as pericoronitis, root resorption, gum and alveolar bone disease (periodontitis), caries and the development of cysts and tumours」「When surgical removal is performed in older people, the risk of postoperative complications, pain and discomfort is increased」｜caveat：此兩句為該回顧的背景敘述，不是其比較兩組後得出的結果；本卡在正文已逐句標明其層級，禁被引用為該回顧的結論。
• F5｜同一回顧之納入研究與其限制：本次更新納入與前版相同的兩項研究，一項為英國牙科醫院場域之平行分組隨機對照試驗，一項為美國私人執業部門之前瞻世代研究；世代研究之次族群為 416 位健康男性參與者、年齡 24 至 84 歲；該研究中關於蛀牙風險，證據不足以顯示有無阻生智齒之差異；隨機對照試驗隨機分派 164 人、實際分析 77 位青少年參與者，比較拔除與保留對五年後牙弓尺寸變化之影響，該研究為高偏差風險且未顯示拔除對牙弓尺寸變化有臨床上顯著效果；無任何符合資格之研究報告拔除相對於保留對健康相關生活品質之影響｜來源 #1｜confidence=verified｜basis=peer_reviewed（PMID 32368796）｜period=2020｜geo: universal｜span:「This review update includes the same two studies that were identified in our previous version of the review: one RCT with a parallel-group design, which was conducted in a dental hospital setting in the United Kingdom, and one prospective cohort study, which was conducted in the private sector in the USA」「One prospective cohort study, reporting data from a subgroup of 416 healthy male participants, aged 24 to 84 years」「during a follow-up period of three to over 25 years」「there is insufficient evidence to demonstrate a difference in caries risk associated with the presence or absence of impacted wisdom teeth」「One RCT with 164 randomised and 77 analysed adolescent participants compared the effect of extraction with retention of asymptomatic disease-free impacted wisdom teeth on dimensional changes in the dental arch after five years」「No evidence from this study, which was at high risk of bias, was found to suggest that removal of asymptomatic disease-free impacted wisdom teeth has a clinically significant effect on dimensional changes in the dental arch」「No eligible studies in this review reported the effects of removal compared with retention of asymptomatic disease-free impacted wisdom teeth on health-related quality of life」｜caveat：世代研究之次族群全為男性，其牙周炎結果不得外推至女性；「沒有證據顯示有效果」不等於「已證明無效果」，本卡在正文已標明此區別。
• F6｜英國衛生科技評估報告（下顎阻生智齒預防性拔除相對於保留與常規照護之系統性回顧與經濟評估；臨床回顧納入 4 項世代研究與 9 篇系統性回顧）：若已有病理變化，英國國家健康與照顧卓越研究院當時之指引立場為該阻生智齒應予拔除；三項報告保留後果之研究中，被保留的下顎阻生智齒之拔除率自 5.5% 至 31.4% 不等，該差異可由追蹤期不同（1 年與 5 年）解釋；兩項報告手術併發症之研究中未報告嚴重併發症；比較預防性拔除與保留及常規照護之證據非常有限；該評估團隊自建之探索性模型結果顯示預防性拔除可能為較具成本效益之策略；其限制第一項即為未找到頭對頭試驗｜來源 #2｜confidence=verified｜basis=peer_reviewed（PMID 32589125，Health Technology Assessment 系統性回顧與經濟評估）｜period=2020（檢索至 2016-04-29）｜geo: universal｜span:「If there are pathological changes, the current National Institute for Health and Care Excellence guidance states that the impacted third molar should be removed」「The clinical review identified four cohort studies and nine systematic reviews」「Pathological changes due to retention of asymptomatic impacted mandibular third molars were reported by three studies」「In the two studies that reported on surgical complications, no serious complications were reported」「the extraction rate for retained impacted mandibular third molars varied from 5.5% to 31.4%; this variation can be explained by the differing follow-up periods (i.e. 1 and 5 years)」「The evidence comparing the prophylactic removal of impacted mandibular third molars with retention and standard care is very limited」「suggest that prophylactic removal may be the more cost-effective strategy」｜caveat：該報告之指引立場與經濟模型屬英國國民保健體系脈絡，非台灣或日本規範，亦非本站對任何國家制度之陳述；經濟模型以英國成本與效用資料建構，本卡不引用其任何金額或成本效益比值；模型為探索性、建立於觀察性資料，作者自載未找到頭對頭試驗。
• F7｜系統性回顧與統合分析（13 項研究、13,788 位病人；依 Newcastle-Ottawa Scale 評估品質）：與下顎阻生智齒相鄰之下顎第二大臼齒遠心面蛀牙之整體盛行率為 29.89%（95% CI 21.05% 至 38.74%，p < 0.001）；依 Winter 分類，近中傾斜位置與蛀牙關聯較高，為 43.37%（95% CI 33.03% 至 53.70%，p < 0.001）｜來源 #3｜confidence=verified｜basis=peer_reviewed（PMID 39853442，系統性回顧與統合分析，PROSPERO CRD42023393143）｜period=2025（納入近十年發表之研究）；檢索日 2026-08-06｜geo: universal｜span:「Thirteen studies met the inclusion criteria and underwent analysis; they included a total of 13,788 patients」「The overall prevalence of caries in MSMs adjacent to IMTMs was 29.89% (CI 95%: 21.05 - 38.74%; p < 0.001)」「Following Winter's classification, the mesioangular position was the most frequently associated with caries with 43.37% (CI 95%: 33.03 - 53.70%; p < 0.001)」｜caveat：該回顧未設置無阻生智齒之對照組，所報告者為盛行率而非風險差，不得被讀成拔除可減少該比例，亦不得作為個人機率；納入研究以影像與臨床診斷為主，族群跨多國。
• F8｜系統性回顧與統合分析（影像上齒冠周間隙正常（≤3 公釐）之無症狀阻生智齒的齒冠周濾泡；7 項研究、592 個濾泡；以 Joanna Briggs Institute 工具評估偏差風險，多數為中度風險、1 項為高風險；檢索至 2025-11）：囊性變化之合併盛行率為 26.7%（95% CI 3.7% 至 49.6%）、含齒囊腫為 21.6%（95% CI 12.9% 至 32.2%），兩者異質性極高（I2 大於 97%）；作者結論為這些發現須謹慎解讀，且現有證據並不支持僅憑這些發現進行預防性拔除｜來源 #4｜confidence=verified｜basis=peer_reviewed（PMID 42144023，系統性回顧與統合分析，線上先行版）｜period=2026；檢索日 2026-08-06；esummary pubtype 無 Retracted Publication｜geo: universal｜span:「in pericoronal follicles with a normal radiographic appearance (≤3 mm) associated with asymptomatic impacted third molars」「Seven studies (592 pericoronal follicles) were included」「The pooled prevalences of cystic changes and dentigerous cysts were respectively 26.7%, (95% CI: 3.7 to 49.6%) and 21.6% (95% CI: 12.9 to 32.2%), both with very high heterogeneity (I2 > 97%)」「current evidence does not support prophylactic extraction based solely on these findings」｜caveat：分母為被手術取下並送組織病理檢查之齒冠周濾泡，非全人口之無症狀智齒；異質性極高（I2 大於 97%）使合併值不穩定；與 F9 之 5.3% 定義與分母皆不同，禁比較或相加。
• F9｜系統性回顧（僅納入以組織病理診斷病灶之研究；自 1,300 篇篩得 16 篇；以 Joanna Briggs Institute 盛行率研究工具評估偏差風險，7 篇高、7 篇中、2 篇低）：與阻生智齒相關之齒源性囊腫與腫瘤盛行率為 5.3%（95% CI 3.1% 至 8.1%）；其中囊腫 4.4%（95% CI 2.5% 至 6.8%）、腫瘤 0.5%（95% CI 0.2% 至 0.9%）｜來源 #5｜confidence=verified｜basis=peer_reviewed（PMID 31005378，系統性回顧）｜period=2019；**版本時效已查——2026-08-06 以 `impacted third molar*[Title] AND prevalence[Title] AND (systematic review[pt] OR meta-analysis[pt])` 檢索回傳 1 筆即本篇；另檢得 2026 年範圍更窄之 F8 並陳，本卡以 F8 為現行且更貼題者｜geo: universal｜span:「From 1,300 studies identified, 16 met the inclusion criteria」「The prevalence of odontogenic cysts and tumors associated with ITM was 5.3% (95%CI: 3.1%-8.1%) of ITM」「Odontogenic cysts in particular were found in 4.4% (95%CI: 2.5-6.8%) of the extracted ITM, whilst odontogenic tumors in 0.5% (95%CI: 0.2-0.9%)」｜caveat：分母為已被拔除之阻生智齒（原文即寫 extracted ITM），存在選擇性偏差，不得讀為全人口阻生智齒的發生率或個人機率**；7 篇納入研究為高偏差風險。
• F10｜回溯觀察研究（在阻生智齒持續存在之前提下，比較兩時間點第二大臼齒遠心面之影像骨水準；51 位病人、平均年齡 45 歲、68 顆第二大臼齒、平均間隔 20 個月）：垂直向、斜向與角度骨水準於兩時間點間無顯著變化；作者結論為本分析未提供證據支持「預防性拔除阻生智齒可帶來顯著保骨效益」之假說，亦未確立長期保留阻生智齒必然導致鄰近第二大臼齒之短期骨變化｜來源 #6｜confidence=verified｜basis=peer_reviewed（PMID 40647642，回溯觀察研究）｜period=2025；檢索日 2026-08-06｜geo: universal｜span:「A total of 51 patients met the inclusion criteria, with a mean age of 45 years (SD ± 13)」「Sixty-eight second molars were assessed at baseline (T0) and follow-up (T1), with a mean interval of 20 months (SEM ± 62 days). No significant changes were found in vertical, oblique, or angular bone levels between T0 and T1」「this analysis does not provide evidence to support the hypothesis that prophylactic extraction of ITMs yields significant bone-sparing benefits」｜caveat：單中心、樣本小、平均間隔僅 20 個月，屬短期觀察；作者明言需更多研究評估中長期影響；不得作為長期保留安全性的證據。
• F11｜冠周炎處置之敘事回顧與抗生素開立之系統性回顧：實證建議為局部治療優先於開立抗生素，抗生素應保留給嚴重情況；牙醫師問卷顯示將近 75% 會為冠周炎開立抗生素，病人資料研究顯示超過半數冠周炎病人被開立抗生素；作者將冠周炎的不適當處置列為牙科抗生素過度使用的關鍵因素｜來源 #7｜confidence=verified｜basis=peer_reviewed（PMID 34202699，敘事回顧＋系統性回顧，檢索期 2000-01 至 2021-05）｜period=2021｜geo: universal｜span:「recommending the local therapy over antibiotic prescribing, which should be reserved for severe conditions」「Questionnaires among dentists revealed that almost 75% of them prescribed antibiotics for pericoronitis」「Studies involving patients showed that antibiotics were prescribed to more than half of the patients with pericoronitis」｜caveat：開藥比例來自跨國問卷與病歷研究，非任一特定地區之現況，亦非對任何醫師處方之評價；本卡引用其處置順序原則；同 KM-DENTAL-05 卡 F11 錨。
• F12｜Cochrane 系統性回顧（下顎智齒手術拔除之不同手術方法；62 項試驗、4643 位參與者；33 項評為高偏差風險、29 項不清楚）：背景載明手術拔除下顎智齒之適應症為緩解局部疼痛、腫脹與張口受限，以及預防偶爾可能危及生命之感染擴散；手術常伴隨短期術後疼痛、腫脹與張口受限，較不常見者為感染、乾槽症（齒槽骨炎）與三叉神經損傷｜來源 #8｜confidence=verified｜basis=peer_reviewed（PMID 32712962，Cochrane 系統性回顧 CD004345.pub3）｜period=2020（檢索至 2019-07-08）；版本鏈已查——2026-08-06 以 `CD004345` 檢索回傳 2 筆（25069437／32712962），本篇為現行版；pubtype 無 Retracted Publication｜geo: universal｜span:「The indications for surgical removal of these teeth are alleviation of local pain, swelling and trismus, and also the prevention of spread of infection that may occasionally threaten life」「Surgery is commonly associated with short-term postoperative pain, swelling and trismus. Less frequently, infection, dry socket (alveolar osteitis) and trigeminal nerve injuries may occur」「We included 62 trials with 4643 participants」｜caveat：背景所述之適應症與併發症為該回顧的敘述，非其比較結果；該回顧多數比較之結論為證據不足以判定各手術方法之差異；本卡不描述任何手術操作方式。
• F13｜系統性回顧（下顎阻生智齒拔除後下齒槽神經損傷之風險關係；自 693 篇篩得 23 項研究，合計 26,427 位病人、44,171 顆牙；檢索期 1990-01 至 2019-03）：在該 44,171 例拔除中，1.20% 發生暫時性下齒槽神經功能缺損、0.28% 發生永久性缺損；統計上顯著之風險因子為阻生深度、下顎管與智齒之接觸、手術方法、術中神經暴露與術者經驗｜來源 #9｜confidence=verified｜basis=peer_reviewed（PMID 31476533，系統性回顧）｜period=2020；**版本時效已查——2026-08-06 以 `(inferior alveolar nerve[Title] OR nerve injury[Title]) AND third molar*[Title] AND (systematic review[pt] OR meta-analysis[pt])` 依日期排序檢索回傳 12 筆，較新之同題回顧為 F14（2026 年，主題為影像預測因子），兩者口徑不同故並陳｜geo: universal｜span:「Twenty-three studies out of 693 articles from the initial search were finally included, which summed up a total of 26,427 patients (44,171 teeth)」「Among 44,171 IMTM extractions performed by various grades of operators, 1.20% developed transient IAN deficit and 0.28% developed permanent IAN deficit respectively」「Depth of impaction (P<0.001), contact between mandibular canal (MC) and IMTM (P<0.001), surgical technique (P<0.001), intra-operative nerve exposure (P<0.001), and surgeon's experience (P<0.001) were statistically significant as contributing risk factors of IAN deficits」｜caveat：納入研究之術者層級不一（原文寫 various grades of operators），比例為跨研究彙總而非任一場域之現況，不得作為個人風險估計，亦不得作為對任何醫師或院所之能力評價**；該回顧未進行統合分析。
• F14｜系統性回顧與統合分析（第三大臼齒手術之下齒槽神經損傷斷層影像預測因子；18 項研究、辨識出 8 項影像特徵；16 項研究為低偏差風險；GRADE 評為中度至高度確定性；PROSPERO CRD42024582042）：勝算比顯著上升者為皮質骨缺失（OR 9.87，95% CI 4.10 至 23.83）、啞鈴形下顎管（OR 8.25，95% CI 3.19 至 21.35）與舌側位置（OR 3.82，95% CI 1.95 至 7.39）；同時具備此三項特徵者風險上升（OR 5.06，95% CI 2.23 至 11.39）｜來源 #10｜confidence=verified｜basis=peer_reviewed（PMID 41770179，系統性回顧與統合分析）｜period=2026；檢索日 2026-08-06；esummary pubtype 無 Retracted Publication｜geo: universal｜span:「In 18 studies, researchers identified 8 tomographic features that predict IAN injury during third-molar extraction. Sixteen studies had a low risk of bias」「The Grading of Recommendations Assessment, Development and Evaluation framework indicated moderate to high certainty of evidence」「Significant increases in odds ratios (ORs) (with P < .001) were observed for the absence of cortical bone (OR, 9.87; 95% CI, 4.10 to 23.83), a dumbbell-shaped canal (OR, 8.25; 95% CI, 3.19 to 21.35), and a lingual position (OR, 3.82; 95% CI, 1.95 to 7.39」「Patients exhibiting all 3 features had an increased risk of experiencing IAN injury after mandibular third-molar extraction (OR, 5.06; 95% CI, 2.23 to 11.39)」｜caveat：勝算比為相對量度、非絕對風險；影像判讀屬醫師與口腔顎面放射專業之工作，本卡不提供任何自行判讀方法；原文第三項勝算比之括號在來源中未閉合，本卡 span 照原文節錄至數值處。
• F15｜系統性回顧與統合分析（與下顎管接觸之下顎智齒行齒冠切除術之併發症；以 RoB 2.0 評估偏差風險；疼痛結果分析納入介入組 1,037 例事件與對照組 1,054 例事件）：感覺異常之相對風險顯著降低（0.09，95% CI 0.03 至 0.25，P < .001，I2 為 0%）；感染風險（P = .370，I2 為 56%）與乾槽症風險（P = .230，I2 為 27%）則無顯著降低；異質性與樣本數使 GRADE 證據確定性自極低至中度｜來源 #11｜confidence=verified｜basis=peer_reviewed（PMID 40562625，系統性回顧與統合分析）｜period=2025；檢索日 2026-08-06｜geo: universal｜span:「A significant reduction in the relative risk of paresthesia was observed (0.09 [95% CI: 0.03, 0.25], P < .001) with low heterogeneity (I² = 0%)」「there was no significant reduction in the risk of infection (P = .370, I² = 56%) or dry socket (P = .230, I² = 27%)」「the heterogeneity (I² = 0%-56%) and sample sizes reduced the certainty of the GRADE evidence from very low to moderate」｜caveat：適用範圍限於與下顎管接觸之下顎智齒，非所有智齒；齒冠切除術保留牙根，後續可能需追蹤或再處置，該回顧未涵蓋長期追蹤結果；本卡不建議任何術式。
• F16｜系統性回顧與統合分析（第三大臼齒拔除對生活品質之影響；自 1,141 篇篩得 13 篇，其中 6 篇進入統合分析；納入條件包含處置係在局部麻醉下執行；以 Newcastle-Ottawa Scale 評估品質）：以 OHIP-14 量表衡量，術後第一天之分數較術前高出 17.57（95% CI 11.84 至 23.30，I2 為 96%）；結論為對生活品質之負面衝擊出現在術後第一天，之後隨追蹤期下降｜來源 #12｜confidence=verified｜basis=peer_reviewed（PMID 29797177，系統性回顧與統合分析）｜period=2018（檢索至 2017-03）；**版本時效已查——2026-08-06 以 `third molar*[tiab] AND quality of life[tiab] AND (systematic review[pt] OR meta-analysis[pt]) AND 2019:2026[dp]` 檢索回傳 14 筆，經逐筆比對主題後未見同題之更新版系統性回顧｜geo: universal｜span:「besides procedures performed under local anesthesia」「A total of 1141 studies were identified. Of this total, 13 articles were selected in the present systematic review, of which six studies were included in the meta-analysis」「The OHIP-14 mean score on the first postoperative day was 17.57 (95% CI 11.84-23.30, I2 = 96%) higher than the preoperative period」「This systematic review revealed that the highest negative impact on quality of life of individuals submitted to third molar surgery was observed on the first postoperative day, decreasing over the follow-up period」｜caveat：I2 為 96%，研究間差異極大，該分數不得作為個人可預期值**；OHIP-14 為量表分數而非疼痛強度；納入研究限於局部麻醉下之處置，不涵蓋鎮靜或全身麻醉情境。
• F17｜橫斷回溯研究（單中心，印尼，2017 至 2019 年下顎智齒手術拔除病例；916 位對象，女性 59%，21 至 30 歲組占 60.9%，複雜級別占 77%）：手術困難度與術後第一天之疼痛、張口受限與感覺異常有顯著相關；年齡與術後一週之疼痛、腫脹與張口受限有顯著相關；作者建議牙醫師留意 51 歲以上與手術複雜度高之病人較易發生較嚴重之術後併發症｜來源 #13｜confidence=verified｜basis=peer_reviewed（PMID 35027927，橫斷回溯研究）｜period=2022；檢索日 2026-08-06｜geo: universal｜span:「Among 916 respondents, the majority of the sample was females (59%) and the dominant age group (60.9%) was the age group of 21-30 years while the dominant surgical difficulty level was shown by the advanced cases group (77%)」「there was a significant correlation between surgical difficulty level and postoperative complications including pain, trismus, and paresthesia on the first-day assessment. On the other hand, age was significantly related to complications like pain, swelling, and trismus on the first-week assessment」「Dentists should take into consideration that older patients (≥51 years) and patients with complex surgical level are more vulnerable to severe postoperative complications」｜caveat：單中心回溯研究、非隨機分派，不能證明因果；與 F18 結論方向不一致，本卡兩者並陳且未擇一採信。
• F18｜回溯分析（單中心，德國，2023-07 至 2024-07；200 位病人、554 顆阻生智齒；以 30 歲為切點分組，分析下齒槽神經感覺遲鈍、口竇交通、舌神經感覺遲鈍、術後出血與術後感染）：下齒槽神經感覺遲鈍、舌神經感覺遲鈍、術後出血與術後感染在兩年齡組間無顯著差異；作者結論為年齡（以 30 歲為切點）與較高之術後併發症風險無統計上相關，與近期若干出版品相反｜來源 #14｜confidence=verified｜basis=peer_reviewed（PMID 39375233，回溯分析）｜period=2024；檢索日 2026-08-06｜geo: universal｜span:「The clinical findings, digital panoramic radiographs and perioperative data of 200 patients (554 impacted third molars) that had been subjected to tooth extraction, from July 2023 until July 2024, were analyzed」「IAN hypesthesia, LN hypesthesia, postoperative bleeding and postoperative infection did not show any significant differences regarding patients' age」「The current findings suggest that age (cut-off 30 years) does not statistically correlate with a higher risk for postoperative complications in impacted third molar surgery in contrast to recent publications」｜caveat：單中心、樣本 200 人、切點為 30 歲，與 F17 之 51 歲切點不可直接比較；「未發現顯著差異」不等於「已證明無差異」，本卡在正文已標明此區別。本研究分析的是年齡與併發症的關係，摘要未報告「手術困難度與併發症」之相關性，故不得與 F17 的困難度結論合併敘述（本卡初稿曾誤寫成兩份研究皆指出困難度相關，已於反例驗階段更正）。
• F19｜Cochrane 系統性回顧（拔牙後併發症之預防性抗生素；23 項試驗、約 3,206 位受試者隨機分派、2,583 位納入分析；16 項評為高偏差風險）：相對於安慰劑，預防性抗生素可能使阻生智齒拔除後之術後感染性併發症風險降低約 66%（RR 0.34，95% CI 0.19 至 0.64；低確定性證據），即平均每治療 19 人（95% CI 15 至 34）可避免一人發生感染；23 項試驗中有 21 項僅納入接受阻生智齒手術之健康人，無任何研究評估免疫功能低下者之拔牙；結論建議臨床醫師應依每位病人之臨床狀況個別評估是否以及何時開立預防性抗生素｜來源 #15｜confidence=verified｜basis=peer_reviewed（PMID 33624847，Cochrane 系統性回顧 CD003811.pub3）｜period=2021（檢索至 2020-04-16）；版本鏈已查——2026-08-06 以 `CD003811` 檢索回傳 2 筆（23152221／33624847），本篇為現行版；pubtype 無 Retracted Publication｜geo: universal｜span:「We included 23 trials that randomised approximately 3206 participants (2583 analysed) to prophylactic antibiotics or placebo」「which means that 19 people (95% CI 15 to 34) need to be treated with antibiotics to prevent one infection following extraction of impacted wisdom teeth」「None of the studies evaluated tooth extraction in immunocompromised patients」「clinicians should evaluate if and when to prescribe prophylactic antibiotic therapy before a dental extraction for each patient on the basis of the patient's clinical conditions」｜caveat：藥名與劑量為該回顧比較之研究介入，本卡一律不引用、不建議；證據確定性為低；結果不必然可推及有共病或感染風險較高者。
• F20｜Cochrane 系統性回顧（成人症狀性根尖周炎與急性根尖膿瘍之全身性抗生素）：臨床指引建議此類狀況之初始治療應為以局部手術性措施移除發炎或感染來源，全身性抗生素目前僅建議用於有感染擴散跡象（蜂窩性組織炎、淋巴結侵犯、瀰漫性腫脹）或全身性影響（發燒、倦怠）之情形｜來源 #16｜confidence=verified｜basis=peer_reviewed（PMID 38712714，Cochrane 系統性回顧 CD010136.pub4）｜period=2024（檢索至 2022-11）；版本鏈沿用 KM-DENTAL-33 卡之查核（`CD010136` 回傳 3 筆，本篇 pub4 為現行版、pubtype 無 Retracted Publication）｜geo: universal｜span:「Clinical guidelines recommend that the first-line treatment for these conditions should be removal of the source of inflammation or infection by local operative measures, and that systemic antibiotics are currently only recommended for situations where there is evidence of spreading infection (cellulitis, lymph node involvement, diffuse swelling) or systemic involvement (fever, malaise)」｜caveat：該回顧之主題為根尖來源之感染，非冠周炎；本卡引其為紅旗判準之來源，其感染擴散與全身性影響之描述屬醫師判斷之判準，本卡轉為病人可觀察並回報之項目，非自我診斷準則；同 KM-DENTAL-33 卡 F15 錨。
• F21｜教科書條目（深頸部感染）：症狀常來自對呼吸道、神經或消化道之局部壓迫效應，包括頸部腫脹、吞嚥困難、發聲困難與張口受限；臨床表現常伴隨發燒、頸部疼痛與呼吸窘迫；宿主因素（免疫功能受抑制狀態、共病、外傷、近期器械操作、靜脈藥物使用）可影響感染之擴散與嚴重度｜來源 #17｜confidence=verified｜basis=textbook（PMID 30020634，StatPearls 條目）｜period=條目版本 2026-01；檢索日 2026-08-06｜geo: universal｜span:「Symptoms often result from local pressure effects on the respiratory, nervous, or gastrointestinal tracts, including neck swelling, dysphagia, dysphonia, and trismus」「often involving fever, neck pain, and respiratory distress」「host factors such as immunocompromised states, comorbid conditions, trauma, recent instrumentation, and intravenous drug use can influence the spread and severity of infections」｜caveat：教科書層級（basis 階梯之下層）、非系統性回顧；深頸部感染之來源不限牙源性；本卡僅引其症狀清單作為紅旗依據，未引任何發生率或預後數字；來源未列舉之徵象本卡不自行增列；同 KM-DENTAL-05／33 卡同錨。
• F22｜《醫療法》第 87 條第 2 項：醫學新知或研究報告之發表、病人衛生教育、學術性刊物，未涉及招徠醫療業務者，不視為醫療廣告｜來源 #19｜confidence=verified（2026-08-05 實測 200、逐字對得上，跨卡沿用）｜basis=law｜period=現行條文｜geo: TW｜caveat：本卡發布定位依據，屬台灣制度，非醫學事實；其他地區讀者請以所在地規範為準。
• F23［結構性整理］｜證據缺口聲明：本站於 2026-08-06 以 PubMed E-utilities 檢索「一次拔幾顆」之排程問題，下列檢索式回傳筆數為——①`third molar[tiab] AND number of teeth extracted per session[tiab]` 回傳 0 筆；②`bilateral extraction[tiab] AND unilateral extraction[tiab] AND third molar[tiab]` 回傳 0 筆；③`simultaneous bilateral extraction[tiab] AND third molar[tiab] AND complication*[tiab]` 回傳 0 筆；④`third molar[Title] AND (single visit[Title] OR one visit[Title] OR same session[Title])` 回傳 0 筆；⑤`staged removal[tiab] AND third molar[tiab]` 回傳 1 筆，經檢視為齒冠切除術結果評估（PMID 27656565），與本題排程問題無關。即未取得直接比較「同次拔除多顆」與「分次拔除」之研究，故本卡不提供任何顆數建議、不比較同側與異側、不建議任何麻醉方式。另本卡未取得可引用之「同次拔兩顆是否使術後不適加倍」之研究，故不作任何倍數陳述｜來源 #20｜confidence=n/a｜basis=editorial_framework｜period=2026-08-06｜geo: universal｜caveat：檢索侷限於 PubMed 與上列檢索式，未取得不等於已被推翻；本欄為編輯性陳述，不得標為待驗 claim。

來源清單

取用日期均為 2026-08-06；PubMed 條目均以 E-utilities efetch 取得摘要原文逐字比對，全卡未使用任何取自付費牆全文之逐字引用。

1. Ghaeminia H, Nienhuijs ME, Toedtling V, et al. Surgical removal versus retention for the management of asymptomatic disease-free impacted wisdom teeth. Cochrane Database Syst Rev. 2020;5(5):CD003879. PMID 32368796
2. Hounsome J, Pilkington G, Mahon J, et al. Prophylactic removal of impacted mandibular third molars: a systematic review and economic evaluation. Health Technol Assess. 2020;24(30):1-116. PMID 32589125
3. Revuelta-Cortés P, Cortés-Bretón Brinkmann J, Argandoña-Flores M, et al. Prevalence of distal caries in second molar associated with impacted mandibular third molar and the position and level of impaction: a systematic review and meta-analysis. Clin Oral Investig. 2025;29(1):83. PMID 39853442
4. de Andrade Tutu JS, de Sousa Lopes Cascaes P, Peralta-Mamani M, et al. Cystic and Neoplastic Lesions in Pericoronal Follicles of Asymptomatic Third Molars: A Systematic Review and Meta-Analysis. J Oral Maxillofac Surg. 2026 May 1 (online ahead of print). PMID 42144023
5. Mello FW, Melo G, Kammer PV, Speight PM, Rivero ERC. Prevalence of odontogenic cysts and tumors associated with impacted third molars: A systematic review and meta-analysis. J Craniomaxillofac Surg. 2019;47(6):996-1002. PMID 31005378
6. Alqahtani ND, et al. Retention of Asymptomatic Impacted Third Molars: Effects on Alveolar Bone at the Distal Surface of Second Molars over Time. Diagnostics (Basel). 2025;15(13):1643. PMID 40647642
7. Schmidt J, Kunderova M, Pilbauerova N, Kapitan M. A Review of Evidence-Based Recommendations for Pericoronitis Management and a Systematic Review of Antibiotic Prescribing for Pericoronitis among Dentists. Int J Environ Res Public Health. 2021;18(13):6796. PMID 34202699
8. Bailey E, Kashbour W, Shah N, Worthington HV, Renton TF, Coulthard P. Surgical techniques for the removal of mandibular wisdom teeth. Cochrane Database Syst Rev. 2020;7(7):CD004345. PMID 32712962
9. Kang F, Sah MK, Fei G. Determining the risk relationship associated with inferior alveolar nerve injury following removal of mandibular third molar teeth: A systematic review. J Stomatol Oral Maxillofac Surg. 2020;121(1):63-69. PMID 31476533
10. Bussolar R, et al. Predictive factors in tomographic imaging for inferior alveolar nerve injury during third-molar surgery: A systematic review and meta-analysis. J Am Dent Assoc. 2026 Aug. PMID 41770179
11. Complications in coronectomy procedures for removal of lower third molars in contact with the mandibular canal: systematic review and meta-analysis of clinical trials. Oral Surg Oral Med Oral Pathol Oral Radiol. 2025 Nov. PMID 40562625
12. Vieira WA, et al. Third molar removal and its impact on quality of life: systematic review and meta-analysis. Qual Life Res. 2018;27(10):2477-2489. PMID 29797177
13. Rizqiawan A, et al. Postoperative Complications of Impacted Mandibular Third Molar Extraction Related to Patient's Age and Surgical Difficulty Level: A Cross-Sectional Retrospective Study. Int J Dent. 2022;2022:7239339. PMID 35027927
14. Krüger C, et al. Impacted third molar surgery in older patients-Is patient's age really a risk factor for complications? Clin Oral Investig. 2024;28(10):568. PMID 39375233
15. Lodi G, Azzi L, Varoni EM, et al. Antibiotics to prevent complications following tooth extractions. Cochrane Database Syst Rev. 2021;2(2):CD003811. PMID 33624847
16. Cope AL, Francis N, Wood F, Thompson W, Chestnutt IG. Systemic antibiotics for symptomatic apical periodontitis and acute apical abscess in adults. Cochrane Database Syst Rev. 2024;5(5):CD010136. PMID 38712714
17. Almuqamam M, Gonzalez FJ, Sharma S, Kondamudi NP. Deep Neck Infections. StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 30020634
18. 內部數據：`km-production-queue.html` 三、診所補題區「智齒一定要拔嗎」列（曝光與來源站逐筆可對帳）
19. 醫療法 第 87 條（全國法規資料庫）
20. 編輯框架：本站三層分流結構、分母標註原則、排程問題之處理方式與證據缺口聲明（無外部來源，標示為結構性整理）

內部引用鏈

• 拔完之後傷口多久長好、每天會經歷什麼（本卡不重寫術後時程）：拔牙的洞要多久才會長好？（KM-DENTAL-01）
• 拔完多久能吃東西、該吃什麼：拔牙後多久能吃東西喝水？該吃什麼？（KM-DENTAL-04）
• 拔完多久可以刷牙、可以用牙膏嗎：拔牙後多久可以刷牙？可以用牙膏嗎？（KM-DENTAL-40）
• 智齒與第三大臼齒在齒列中的位置、第二大臼齒為什麼重要：臼齒是哪幾顆？第二大臼齒為什麼重要？（KM-DENTAL-21）
• 智齒周圍已經腫痛時的三級分流與紅旗（本卡 F11／F20／F21 與該卡同錨）：牙齦腫痛怎麼快速消？什麼情況要就醫？（KM-DENTAL-05）
• 牙齒本身在痛時的形態分流（本卡 F20／F21 與該卡 F15／F17 同錨）：牙齒痛怎麼辦？蛀牙痛是什麼感覺？（KM-DENTAL-33）

發布閘門提醒：本卡為 draft。四語（zh-Hans／en／ja）未產前不得進 km_entries；地域聲明四語版本必齊（global 卡措辭見 ANK-DENTAL-SPEC.md）。本卡為症狀分級卡且含紅旗判準，依審核鏈需 GM 第三意見（高風險）。 本卡 topic_id 為 KM-DENTAL-C01（診所補題序列），km-gate.py 的掛載檢查以 `KM-DENTAL-<數字>` 比對主佇列表格，對本卡不會觸發，F6 之英國指引立場與經濟模型屬英國體系脈絡，翻譯為其他語版時禁改寫成讀者所在國之制度。